Mammalian somatic cell with modified RNA encoding reprogramming factors
US12054748B2 · kind B2 · utility
0Cited by
12References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2021 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Mar 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are synthetic, modified RNAs for changing the phenotype of a cell, such as expressing a polypeptide or altering the developmental potential. Accordingly, provided herein are compositions, methods, and kits comprising synthetic, modified RNAs for changing the phenotype of a cell or cells. These methods, compositions, and kits comprising synthetic, modified RNAs can be used either to express a desired protein in a cell or tissue, or to change the differentiated phenotype of a cell to that of another, desired cell type.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.